===================== Product Identification =====================
MSDS NAME:890 8857,KODAK DRC DEVELOPER REPLENISHER (SEE SUPPL DATA)
Status Code:A
MSDS Number: CKTGM
=== Responsible Party ===
Company:EASTMAN KODAK COMPANY
Address:343 STATE STREET
City:ROCHESTER
State:NY
ZIP:14650
Country:US
Info Phone Num:716-722-5151/(800) 242-2424
Emergency Phone Num:716-722-5151
Preparer's Name:NOT PROVIDED
CAGE:19139
=== Contractor Identification ===
Company:EASTMAN KODAK CO GOVERNMENT MARKETS CONTRACTS
Address:343 STATE ST
Box:City:ROCHESTER
State:NY
ZIP:14650-1115
Country:US
Phone:716-722-5151/(800) 242-2424
CAGE:19139
Company:EASTMAN KODAK CO US CUSTOMER SERVICE/GOVERNMENT SALES
Address:800 LEE RD
Box:City:ROCHESTER
State:NY
ZIP:14650-3129
Country:US
Phone:800-828-6203
CAGE:5K871
============= Composition/Information on Ingredients =============
Name:WATER
CAS:7732-18-5
RTECS #:ZC0110000
Minumum % Wt:80.
Maxumum % Wt:85.
Other REC Limits:NOT PROVIDED
Code:F
Code:F
Name:POTASSIUM SULFITE
CAS:10117-38-1
RTECS #:WT3530000
Minumum % Wt:5.
Maxumum % Wt:10.
Other REC Limits:NOT PROVIDED
OSHA PEL:NOT PROVIDED
ACGIH TLV:NOT PROVIDED
Name:DIETHYLENE GLYCOL
CAS:111-46-6
RTECS #:ID5950000
= Wt:2.
Other REC Limits:NOT PROVIDED
OSHA PEL:NOT PROVIDED
ACGIH TLV:NOT PROVIDED
Name:HYDROQUINONE
CAS:123-31-9
RTECS #:MX3500000
= Wt:3.
Other REC Limits:NOT PROVIDED
OSHA PEL:2 MG/M3
ACGIH TLV:2 MG/M3
EPA Rpt Qty:1 LB
DOT Rpt Qty:1 LB
Name:SODIUM BROMIDE
CAS:7647-15-6
RTECS #:VZ3150000
< Wt:1.
Other REC Limits:NOT PROVIDED
OSHA PEL:NOT PROVIDED
ACGIH TLV:NOT PROVIDED
Name:4-(HYDROXYMETHYL)-4-METHYL-1-PHENYL-3-PYRAZOLIDONE (THERE
IS NO CHEMICAL ENDING TO DINONE.)
CAS:13047-13-7
< Wt:1.
Other REC Limits:NOT PROVIDED
OSHA PEL:NOT PROVIDED
ACGIH TLV:NOT PROVIDED
===================== Hazards Identification =====================
LD50 LC50 Mixture:NOT PROVIDED
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION: EXPECTED TO BE A LOW
HAZARD FOR RECOMMENDED HANDLING. IN CONTACT WITH STRONG ACIDS/IF
HEATED, SULFITES MAY LIBERATE SULFUR DIOXIDE GAS WHICH IS
IRRITATING TO RESPIRATORY TRACT. SOME ASTHM ATICS/HYPERSENSITIVE
INDIVIDUALS MAY EXPERIENCE DIFFICULT BREATHING. EYES: CAUSES
IRRITATION. SKIN: PROLONGED OR REPEATED CONTACT MAY CAUSE DRYING,
CRACKING/ IRRITATION. MAY CAUSE ALLERGIC SKIN REACTI ON. INGESTION:
HARMFUL IF SWALLOWED. SOME ASTHMATICS OR SULFITE-SENSITIVE
INDIVIDUALS MAY EXPERIENCE WHEEZING, CHEST TIGHTNESS, STOMACH
UPSET, HIVES, FAINTNESS, WEAKNESS AND DIARRHEA.
Explanation of Carcinogenicity:CARCINOGENICITY CLASSIFICATION
(COMPONENTS PRESENT AT 0.1% OR MORE): - INTERNATIONAL AGENCY FOR
RESEARCH ON CANCER (IARC): NONE - AMERICAN CONFERENCE OF
GOVERNMENTAL INDUSTRIAL HYGIENISTS (ACGIH): NON E - NATIONAL
TOXICOLOGY PROGRAM (NTP): NONE - OCCUPATIONAL SAFETY AND HEALTH
ADMINISTRATION (OSHA): NONE
Effects of Overexposure:INHALATION: SULFUR DIOXIDE GAS IS IRRITATING TO
RESPIRATORY TRACT. SOME ASTHMATICS/HYPERSENSITIVE INDIVIDUALS MAY
EXPERIENCE DIFFICULT BREATHING. EYES: CAUSES IRRITATION. SKIN:
PROLONGED OR REPEATED C ONTACT MAY CAUSE DRYING, CRACKING OR
IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION. INGESTION: SOME
ASTHMATICS OR SULFITE-SENSITIVE INDIVIDUALS MAY EXPERIENCE
WHEEZING, CHEST TIGHTNESS, STOMACH UPSET, HIVES, FAINTNESS,
WEAKNESS AND DIARRHEA. MAY CAUSE IRRITATION OF GASTROINTESTINAL
TRACT.
Medical Cond Aggravated by Exposure:SOME ASTHMATICS, HYPERSENSITIVE OR
SULFITE-SENSITIVE INDIVIDUALS MAY EXPERIENCE DIFFICULT BREATHING,
WHEEZING, CHEST TIGHTNESS, STOMACH UPSET, HIVES, FAINTNESS,
WEAKNESS AND DIARRHEA.
======================= First Aid Measures =======================
First Aid:INHALATION: IF SYMPTOMATIC, MOVE TO FRESH AIR. TREAT
SYMPTOMATICALLY. GET MEDICAL ATTENTION IF SYMPTOMS PERSIST. EYES:
IMMEDIATELY FLUSH WITH PLENTY OF WATER FOR AT LEAST 15 MINUTES. GET
MEDICAL ATTEN TION. SKIN: IMMEDIATELY FLUSH WITH PLENTY OF WATER
FOR AT LEAST 15 MINUTES WHILE REMOVING CONTAMINATED CLOTHING AND
SHOES. IF SKIN IRRITATION OR AN ALLERGIC SKIN REACTION DEVELOPS,
GET MEDICAL ATTENTI ON. WASH CONTAMINATED CLOTHING BEFORE REUSE.
INGESTION: ONLY INDUCE VOMITING AT THE INSTRUCTION OF MEDICAL
PERSONNEL. NEVER GIVE ANYTHING BY MOUTH TO AN UNCONSCIOUS PERSON.
CALL A PHYSICIAN OR POISON CONTROL CENTER IMMEDIATELY.
===================== Fire Fighting Measures =====================
Flash Point:NONE
Extinguishing Media:USE APPROPIATE AGENT FOR ADJACENT FIRE.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
PROTECTIVE CLOTHING. FIRE OR EXCESSIVE HEAT MAY PRODUCE HAZARDOUS
DECOMPOSITION PRODUCTS.
Unusual Fire/Explosion Hazard:NONE.
================== Accidental Release Measures ==================
Spill Release Procedures:FLUSH TO SEWER WITH LARGE AMOUNTS OF WATER.
OTHERWISE ABSORB SPILL WITH VERMICULITE OR OTHER INERT MATERIAL,
THEN PLACE IN A CONTAINER FOR CHEMICAL WASTE.
Neutralizing Agent:NOT PROVIDED
====================== Handling and Storage ======================
Handling and Storage Precautions:AVOID BREATHING MIST OR VAPOR. AVOID
CONTACT WITH EYES, SKIN, AND CLOTHING. USE WITH ADEQUATE
VENTILATION. WSH THOROUGHLY AFTER HANDLING. KEEP CONTAINER CLOSED.
KEEP AWAY FROM INCOMPATIBLE SUBSTANCES.
Other Precautions:AVOID CONTACT WITH EYES, SKIN AND CLOTHING. USE WITH
ADEQUATE VENTILATION. WASH THOROUGHLY AFTER HANDLING.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:NONE SHOULD BE NEEDED. A RESPIRATOR SHOULD BE
WORN IF HAZARDOUS DECOMPOSITION PRODUCTS ARE LIKELY TO BE OR HAVE
BEEN RELEASED. RESPIRATOR TYPE: ACID GAS. SEE STABILITY AND
REACTIVITY SECTION. IF RESPI RATORS ARE USED, A PROGRAM SHOULD BE
INSTITUTED TO ASSURE COMPLIANCE WITH OSHA STANDARD 29 CFR 1910.134.
Ventilation:GOOD GENERAL VENTILATION (TYPICALLY 10 AIR CHANGES/HR)
SHOULD BE USED. VENTILATION RATES SHOULD BE MATCHED TO CONDITIONS
Protective Gloves:WEAR IMPERVIOUS GLOVES APPROPRIATE FOR RISK OF
EXPOSURE.
Eye Protection:WEAR SAFETY GLASSES WITH SIDE SHIELDS (OR GOGGLES).
Other Protective Equipment:WEAR PROTECTIVE CLOTHING APPROPIATE FOR THE
RISK OF EXPOSURE. EYE BATH, SAFETY SHOWER, WASHING FACILITIES.
Work Hygienic Practices:NOT PROVIDED
Supplemental Safety and Health
CONTINUED FROM PRODUCT ID: CONCENTRATE WITH STARTER (WORKING SOLUTION).
SYNONYMS: WORKING SOLUTION: KAN 966350; C-0023.720 CONTAINS:
DEVELOPER: KAN 966133; PCD 5901; C-0023.700 AND STARTER: KAN 354888
; PCD 3463; C-0023.710
================== Physical/Chemical Properties ==================
HCC:B3
NRC/State Lic Num:NOT RELEVANT
Boiling Pt:>100.C, 212.F
Melt/Freeze Pt:M.P/F.P Text:NOT PROVIDED
Decomp Temp:Decomp Text:NOT PROVIDED
Vapor Pres:18 MMHG @ 68F
Vapor Density:0.6
Spec Gravity:1.09
pH:10.9
Viscosity:NOT PROVIDED
Evaporation Rate & Reference:NOT PROVIDED
Solubility in Water:COMPLETE
Appearance and Odor:LIQUID, LIGHT YELLOW, ODORLESS.
Percent Volatiles by Volume:80-85 BY WT
Corrosion Rate:NOT PROVIDED
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
STRONG ACIDS.
Stability Condition to Avoid:NOT PROVIDED
Hazardous Decomposition Products:CARBON DIOXIDE, CARBON MONOXIDE,
SULFUR DIOXIDE.
=================== Toxicological Information ===================
Toxicological Information:CONTAINS: DIETHYLENE GLYCOL. CAN CAUSE KIDNEY
DAMAGE. CONTAINS: HYDROQUINONE. IN F-344 RATS, CHRONIC ORAL
ADMINISTRATION OF HYDROQUINONE HAS RESULTED IN THE FORMATION OF
BENIGN KIDNEY TUMORS THOUGHT T O BE SECONDARY TO NEPHROPATHY.
HYDROQUINONE-INDUCED NEPHROPATHY FOLLOWING ORAL ADMINISTRATION HAS
BEEN NOTED IN MALE BUT NOT IN OTHER SPECIES. ALTHOUGH AN INCREASE
IN MONONUCLEAR CELL LEUKEMIA IN F-3 44 FEMALE RATS HAS BEEN
REPORTED FOLLOWING CHRONIC ORAL ADMINISTRATION OF HYDROQUINONE,
THIS FINDING WAS NOT REPRODUCED IN A SUBSEQUENT STUDY.
===================== Ecological Information =====================
Ecological:IT IS EXPECTED TO HAVE THE FOLLOWING PROPERTIES: A MODERATE
BIOCHEMICAL OXYGEN DEMAND AND MAY CAUSE OXYGEN DEPLETION IN
AQUEOUS SYSTEMS, A HIGH POTENTIAL TO AFFECT SOME AQUATIC
ORGANISMS, A MODERATE POTENTIAL TO AFFECT SECONDARY WASTE
TREATMENT MICROBIAL METABOLISM, A MODERATE POTENTIAL TO AFFECT THE
GERMINATION AND/OR EARLY GROWTH OF SOME PLANTS, A LOW POTENTIAL TO
PERSIST IN THE ENVIRONMENT , A LOW POTENTIAL TO BIOCONCENTRATE.
AFTER DILUTION WITH A LARGE AMOUNT OF WATER, FOLLOWED BY SECONDARY
WASTE TREATMENT, THIS MATERIAL IS NOT EXPECTED TO CAUSE ADVERSE
ENVIRONMENTAL EFFECTS.
==================== Disposal Considerations ====================
Waste Disposal Methods:FLUSH TO SEWER WITH LARGE AMOUNTS OF WATER.
DISCHARGE, TREATMENT, OR DISPOSAL MAY BE SUBJECT TO NATIONAL,
STATE, OR LOCAL LAWS. SINCE EMPTIED CONTAINERS RETAIN PRODUCT
RESIDUE, FOLLOW LABEL WARNINGS E VEN AFTER CONTAINER IS EMPTIED.
=================== MSDS Transport Information ===================
Transport Information:FOR TRANSPORTATION INFORMATION REGARDING THIS
PRODUCT CALL THE KODAK WORLDWIDE TRANSPORTATION HAZMAT HOT LINE:
(716) 722-2400 BETWEEN 8 A.M. AND 5 P.M. (EASTERN STANDARD TIME),
MONDAY THROUGH FRIDAY .
===================== Regulatory Information =====================
SARA Title III Information:CHEMICAL(S) SUBJECT TO THE REPORTING
REQUIREMENTS OF SECTION 313 OR TITLE III OF THE SUPERFUND
AMENDMENTS AND REAUTHORIZATION ACT (SARA) OF 1986 AND 40 CFR
PART 372: HYDROQUINONE, DIETHYLENE GLY COL.
Federal Regulatory Information:NOT PROVIDED
State Regulatory Information:MATERIAL(S) KNOWN TO THE STATE OF
CALIFORNIA TO CAUSE CANCER: NONE - MATERIAL(S) KNOWN TO THE STATE
OF CALIFORNIA TO CAUSE ADVERSE REPRODUCTIVE EFFECTS: NONE
======================= Other Information =======================
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
*** END OF RECORD *** |
|